Understanding Alpha-1 Antitrypsin Deficiency: A Guide for Patients in Oregon
Alpha-1 Antitrypsin Deficiency, commonly called Alpha-1, is a genetic condition that affects an estimated 100,000 Americans. Yet for most people living with it, the road to diagnosis is long. On average, it takes seven to eight years from the first symptoms to a confirmed diagnosis. At Vital Care of Portland, we want to change that experience for patients in our community by making sure they have access to the care and information they need, including convenient infusion therapy close to home.
What Is Alpha-1 Antitrypsin Deficiency?
Alpha-1 is a hereditary condition in which the body produces insufficient amounts of a protein called alpha-1 antitrypsin (AAT). This protein normally protects the lungs from damage caused by inflammation, infections, and environmental irritants like tobacco smoke. When AAT levels are too low, the lungs become vulnerable to progressive damage over time, which can lead to chronic obstructive pulmonary disease (COPD), emphysema, and other serious respiratory conditions. In some patients, Alpha-1 can also affect the liver.
Who Is at Risk?
Alpha-1 can affect people of all backgrounds, but it is most commonly seen in people of Northern European descent. Because its symptoms overlap with other lung conditions, it is frequently misdiagnosed as asthma or COPD. If you or a family member has been diagnosed with COPD at a younger-than-typical age, has unexplained lung disease, or has a family history of emphysema or liver problems, it is worth asking your doctor about Alpha-1 testing.
How Is Alpha-1 Treated?
The primary treatment for Alpha-1-related lung disease is augmentation therapy, regular intravenous (IV) infusions of purified AAT protein. Augmentation therapy does not cure Alpha-1, but it helps raise AAT levels in the blood and lungs, which may slow the progression of lung disease. The most commonly used medications for augmentation therapy include:
Prolastin-C (alpha-1 proteinase inhibitor)
Glassia (alpha-1 proteinase inhibitor)
Aralast NP (alpha-1 proteinase inhibitor)
These infusions are typically administered once per week and can be given at home with a visiting nurse or at an infusion center.
Alpha-1 Infusion Therapy Near Portland
At Vital Care of Portland, we specialize in the kind of chronic, ongoing infusion therapy that Alpha-1 patients need. Our team works directly with your pulmonologist to coordinate every step of care, from benefits verification and prior authorization through scheduling and ongoing medication management. We offer two convenient site-of-care options:
Home Infusion: Our experienced infusion nurses come to your home, so you can receive therapy in a familiar, comfortable environment.
Infusion Suite: Our private infusion suite in Happy Valley is designed for patients who prefer coming in for treatment. It is quiet, comfortable, and staffed by our CRNI-certified lead infusion nurse.
Getting Started
If you have been diagnosed with Alpha-1 Antitrypsin Deficiency and your physician has recommended augmentation therapy, we are here to help you get started. Our intake coordinator handles the paperwork, insurance verification, and prior authorization from day one, so you can focus on your health rather than the logistics.
Contact our intake team at intake@vitalcareofportland.com, call 971-484-4940, or fax a referral to 971-484-4950. Visit vitalcareofportland.com to learn more about our services.
